Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

Gracell Biotechnologies Presents Updated Data of Deep and Durable Responses for FasTCAR-T GC012F in Relapsed/Refractory Multiple Myeloma at 2023 ASCO Annual Meeting

Data on BCMA/CD19 dual-targeting FasTCAR-T GC012F showed 100% minimal residual disease (MRD) negativity and 82.8% MRD negative stringent complete response (sCR) in a predominantly high-risk relapsed/refractory multiple myeloma (RRMM) population Data on GC012F for treatment of B-NHL will be prese...

2023-06-04 02:15 3246

Sanyou launches new European offices and continues to promote global business landscape

SHANGHAI, June 3, 2023 /PRNewswire/ -- In May 2023, following the CIC Boston branch in US, Sanyou opens new offices in The Shard London and CIC Rotterdam respectively, to rapidly promote the globalization of business landscape. Headquartered in Shanghai China, Sanyou Biopharmaceuticals Co., Ltd. ...

2023-06-03 20:05 3325

Innovent Announces the Second Breakthrough Therapy Designation by NMPA for Olverembatinib for the Treatment of Patients with SDH-Deficient GIST

ROCKVILLE, Md. and SUZHOU, China, June 3, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...

2023-06-03 07:59 22037

Anti- Ageing and Reproductive Medical Giants to Gather in Hong Kong, Dragon's Medical Leads Chinese Medical Development

Hong Kong, June 2, 2023 /PRNewswire/ -- Dragon's Medical will hold its Advance Medical Technology Press Conference 2023 atW Hong Kong on Jun 9, 2023, signing strategic partnership agreements with various medical groups fromChina, Hong Kong and Taiwan, deepening ...

2023-06-02 23:02 5245

United Imaging to Unveil Ultra-Modern MRI Technology Platform at ISMRM in Toronto

In addition to the uMR® Jupiter 5T, the 12-year old company will exhibit its uAIFi artificial intelligence technology platform and translational medical research systems, and present an open MR development platform that includes AI-empowered reconstruction. HOUSTON, June 2, 2023 /PRNewswire/ -- ...

2023-06-02 22:00 4249

Trajan's Microsampling Devices Meet IVDR Compliance in Europe, UK

Mitra® and hemaPEN® receive regulatory certification as medical devices for remote blood sample collection in healthcare, clinical trials and home monitoring programs inEurope and United Kingdom. MELBOURNE, Australia, June 2, 2023 /PRNewswire/ -- Trajan Scientific and Medical, a leading provider...

2023-06-02 20:00 2535

Transcenta Holding Limited (6628.HK) to Hold 2023 ASCO Business Update call Conference.

SUZHOU, China, June 2, 2023 /PRNewswire/ -- The management team of Transcenta Holding Limited (06628.HK) will attend the 2023 ASCO Business Update Call conference onJune 7, 2023. Transcenta is a clinical stage biopharmaceutical company with fully integrated capabilities in the discovery, research...

2023-06-02 19:14 4941

Transcenta Holding Limited (6628.HK) to Hold 2023 ASCO Business Update call Conference.

Latest Updates of 9 Viva's Portfolio Companies

HONG KONG, June 2, 2023 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the succ...

2023-06-02 18:51 3188

Waterdrop Inc. Announces First Quarter 2023 Unaudited Financial Results

BEIJING, June 2, 2023 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced its unaudited financial results for the first quarter endedMarch 31, 20...

2023-06-02 18:16 4326

Invivoscribe Partners with Complete Genomics to Develop and Commercialize Biomarker Tests for Oncology and Cancer Research

SAN DIEGO and SAN JOSE, Calif., June 2, 2023 /PRNewswire/ -- Invivoscribe and Complete Genomics announced today that they had entered a partnership to develop and commercialize biomarker tests on Complete Genomics' NGS platforms. The territory is worldwide, and the field is oncology and cancer...

2023-06-02 18:00 3182

TWi Biotechnology Exploring Promising Treatment for Granuloma Annulare (GA)

Company and Yale University Hospital seeking participants with GA for Phase 1 trials of medicine FDA-approved for other ailments NEW HAVEN, Conn., June 2, 2023 /PRNewswire/ -- TWi Biotechnology (TWiB), a clinical stage biopharmaceutical company specializing in development of repositioned drugs f...

2023-06-02 15:51 1871

Sunway Medical Centre Velocity Awarded by Frost & Sullivan for Leading the Malaysian Hospital Industry with Holistic Medical Care and Pioneering Technologies

Sunway Medical Centre Velocity in Kuala Lumpur delivers a wide range of medical specialties supported by highly trained professionals and advanced technologies. SAN ANTONIO, June 2, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the Malaysian hospital industry and, based on its finding...

2023-06-02 11:46 2714

Sunway Medical Centre Velocity Awarded by Frost & Sullivan for Leading the Malaysian Hospital Industry with Holistic Medical Care and Pioneering Technologies

NMPA accepted Akeso's ebronucimab (PCSK9) marketing application in two cardiovascular indications

HONG KONG, June 1, 2023 /PRNewswire/ -- Akeso Inc. (9926. HK, "Akeso") announced today thatChina's National Medical Products Administration (NMPA) has accepted its New Drug Application (NDA) for its fully human anti-PCSK9 monoclonal antibody ebronucimab (AK102) for 2 indications 1) primary hyper...

2023-06-02 11:43 2000

HeyGears Launches First Professional Desktop 3D Printer for Consumers

IRVINE, Calif., June 2, 2023 /PRNewswire/ -- HeyGears, a leading provider of 3D printing technology and solutions, has announced the global launch of pre-sales for its first desktop 3D printing solution available for consumers, the UltraCraft Reflex. The pre-sale beginsJune 1st via the HeyGears' ...

2023-06-02 10:46 2738

HeyGears Launches First Professional Desktop 3D Printer for Consumers

GC Biopharma receives a business license for the construction of a plasma fractionation plant and technology transfer in Indonesia

* In recognition of securing high-caliber technology in manufacturing plasma derivatives and a track record of overseas plasma fractionation plant construction and technology transfer YONGIN, South Korea, June 1, 2023 /PRNewswire/ -- GC Biopharma, a South Korean biopharmaceutical company, anno...

2023-06-02 08:35 2022

Innovent Enters into Clinical Trial Collaboration with Merck KGaA, Darmstadt, Germany Investigating Combination Therapy of IBI351 (KRASG12C Inhibitor) and Cetuximab (ERBITUX®)for KRASG12C-mutated NSCLC in China

ROCKVILLE, Md. and SUZHOU, China, June 2, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2023-06-02 08:00 5660

CAMH study confirms ongoing brain inflammation associated with long COVID

Researchers using advanced brain imaging are first to find increase in protein marker of inflammation in illness affecting 200 million globally TORONTO, June 2, 2023 /PRNewswire/ -- A new CAMH study published in the journalJAMA Psychiatry found elevated levels of inflammation in the brain of pa...

2023-06-02 04:07 2605

EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally

BEIJING, June 2, 2023 /PRNewswire/ -- EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today announced that it has established a strategic alliance with the China Resources Pharmaceutical Commercial Group, a leading pharmaceutical distribution ent...

2023-06-02 00:10 2805

Sirnaomics Dosed the First Patient in Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment

HONG KONG, Germantown, Md. and Suzhou, China, June 2, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company"; together with its subsidiaries, the "Group" or "Sirnaomics"; stock code: 2257), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today...

2023-06-02 00:06 6702

GenEros to Present Promising Results of GEC255 Phase I Clinical Trial for Advanced NSCLC Patients with KRAS G12C Mutation

HANGZHOU, China, June 1, 2023 /PRNewswire/ -- GenEros Biopharma Ltd. ("GenEros" or "the Company"), a biopharmaceutical company dedicated to discovering, developing, and commercializing novel medicines for diseases with unmet medical needs, will unveil the preliminary data from the phase I clinica...

2023-06-01 22:15 2333

1 ... 145 146 147148149 150 151 ... 808